Absolute Versus Relative Psoriasis Area and Severity Index in Clinical Practice

Actas Dermosifiliogr (Engl Ed). 2019 Sep;110(7):606-610. doi: 10.1016/j.ad.2018.03.029. Epub 2019 Feb 23.
[Article in English, Spanish]
No abstract available

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Adalimumab / adverse effects
  • Adalimumab / therapeutic use*
  • Adult
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use
  • Body Weight
  • Dermatologic Agents / adverse effects
  • Dermatologic Agents / therapeutic use*
  • Etanercept / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Psoriasis / drug therapy*
  • Psoriasis / pathology*
  • Retrospective Studies
  • Severity of Illness Index*
  • Time Factors
  • Treatment Outcome
  • Ustekinumab / adverse effects
  • Ustekinumab / therapeutic use*

Substances

  • Anti-Inflammatory Agents
  • Dermatologic Agents
  • Ustekinumab
  • Adalimumab
  • Etanercept